$14.43
0.161.12%
At Close: -
$14.40
-0.03-0.21%
After Hours: 7:09 PM EDT
15 minutes delayed
Elanco Animal Health
ELANNYSE
Elanco Animal Health (NYSE:ELAN) Stock, Analyst Ratings, Price Targets, Predictions
Elanco Animal Health Inc has a consensus price target of $17.44, established from looking at the 41 latest analyst ratings. The last 3 analyst ratings were released from Barclays, Piper Sandler, and Barclays on June 28, 2024, May 13, 2024, and May 9, 2024. With an average price target of $21 between Barclays, Piper Sandler, and Barclays, there's an implied 45.83% upside for Elanco Animal Health Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Piper Sandler
Goldman Sachs
Morgan Stanley
Stifel
1calculated from analyst ratings
Analyst Ratings for Elanco Animal Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/28/2024 | Buy Now | 45.83% | Barclays | Balaji Prasad | $23 → $21 | Maintains | Overweight | Get Alert |
| 05/13/2024 | Buy Now | 31.94% | Piper Sandler | David Westenberg | $18 → $19 | Reiterates | Neutral → Neutral | Get Alert |
| 05/09/2024 | Buy Now | 59.72% | Barclays | Balaji Prasad | $19 → $23 | Maintains | Overweight | Get Alert |
| 03/12/2024 | Buy Now | 25% | Piper Sandler | David Westenberg | $12 → $18 | Reiterates | Neutral → Neutral | Get Alert |
| 02/27/2024 | Buy Now | -2.78% | Goldman Sachs | Nathan Rich | $12.5 → $14 | Maintains | Sell | Get Alert |
| 02/27/2024 | Buy Now | 18.06% | Morgan Stanley | Erin Wright | $16 → $17 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | 31.94% | Barclays | Balaji Prasad | $18 → $19 | Maintains | Overweight | Get Alert |
| 01/17/2024 | Buy Now | -13.19% | Goldman Sachs | Nathan Rich | $10 → $12.5 | Maintains | Sell | Get Alert |
| 01/05/2024 | Buy Now | 38.89% | Stifel | Jonathan Block | $13 → $20 | Upgrade | Hold → Buy | Get Alert |
| 12/19/2023 | Buy Now | 18.06% | Jefferies | Glen Santangelo | → $17 | Initiates | → Buy | Get Alert |
| 12/15/2023 | Buy Now | 11.11% | Morgan Stanley | Erin Wright | → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/07/2023 | Buy Now | -9.72% | Stifel | Jonathan Block | $12 → $13 | Maintains | Hold | Get Alert |
| 11/13/2023 | Buy Now | -16.67% | Piper Sandler | David Westenberg | $11 → $12 | Maintains | Neutral | Get Alert |
| 11/08/2023 | Buy Now | 11.11% | Morgan Stanley | Erin Wright | $17 → $16 | Maintains | Equal-Weight | Get Alert |
| 10/30/2023 | Buy Now | -16.67% | Stifel | Jonathan Block | $13 → $12 | Maintains | Hold | Get Alert |
| 08/14/2023 | Buy Now | -9.72% | Piper Sandler | David Westenberg | $9 → $13 | Maintains | Neutral | Get Alert |
| 08/09/2023 | Buy Now | -34.03% | Goldman Sachs | Nathan Rich | $8.5 → $9.5 | Maintains | Sell | Get Alert |
| 08/08/2023 | Buy Now | -34.03% | Goldman Sachs | Nathan Rich | $8.5 → $9.5 | Maintains | Sell | Get Alert |
| 04/26/2023 | Buy Now | -37.5% | Goldman Sachs | Nathan Rich | $10.5 → $9 | Maintains | Sell | Get Alert |
| 04/25/2023 | Buy Now | -37.5% | Goldman Sachs | Nathan Rice | $10.5 → $9 | Maintains | Sell | Get Alert |
| 04/20/2023 | Buy Now | -2.78% | Barclays | Balaji Prasad | → $14 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/22/2023 | Buy Now | -2.78% | Barclays | Balaji Prasad | $18 → $14 | Maintains | Equal-Weight | Get Alert |
| 01/30/2023 | Buy Now | 31.94% | Morgan Stanley | Erin Wright | $20 → $19 | Maintains | Equal-Weight | Get Alert |
| 11/15/2022 | Buy Now | 38.89% | Morgan Stanley | Joseph Moore | $21 → $20 | Maintains | Equal-Weight | Get Alert |
| 11/14/2022 | Buy Now | 4.17% | Piper Sandler | David Westenberg | $21 → $15 | Maintains | Neutral | Get Alert |
| 11/09/2022 | Buy Now | -16.67% | Goldman Sachs | Nathan Rich | $19 → $12 | Maintains | Sell | Get Alert |
| 10/17/2022 | Buy Now | 38.89% | JP Morgan | Chris Schott | $24 → $20 | Maintains | Neutral | Get Alert |
| 10/07/2022 | Buy Now | 45.83% | Morgan Stanley | Joseph Moore | $22 → $21 | Maintains | Equal-Weight | Get Alert |
| 09/12/2022 | Buy Now | 25% | Barclays | Balaji Prasad | $32 → $18 | Maintains | Equal-Weight | Get Alert |
| 08/18/2022 | Buy Now | 52.78% | Morgan Stanley | Erin Wright | $37 → $22 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/17/2022 | Buy Now | 45.83% | Piper Sandler | David Westenberg | $22 → $21 | Maintains | Neutral | Get Alert |
| 08/16/2022 | Buy Now | — | JP Morgan | Chris Schott | — | Downgrade | Overweight → Neutral | Get Alert |
| 07/21/2022 | Buy Now | 31.94% | Goldman Sachs | Nathan Rich | $32 → $19 | Downgrade | Buy → Sell | Get Alert |
| 07/18/2022 | Buy Now | 122.22% | JP Morgan | Chris Schott | $37 → $32 | Maintains | Overweight | Get Alert |
| 07/12/2022 | Buy Now | 52.78% | Piper Sandler | David Westenberg | → $22 | Initiates | → Neutral | Get Alert |
| 06/24/2022 | Buy Now | 52.78% | Stifel | Jonathan Block | $30 → $22 | Maintains | Hold | Get Alert |
| 05/19/2022 | Buy Now | 122.22% | Goldman Sachs | Nathan Rich | $37 → $32 | Maintains | Buy | Get Alert |
| 05/17/2022 | Buy Now | 156.94% | Morgan Stanley | Erin Wright | $40 → $37 | Maintains | Overweight | Get Alert |
| 02/28/2022 | Buy Now | 122.22% | Barclays | Balaji Prasad | $30 → $32 | Maintains | Equal-Weight | Get Alert |
| 11/18/2021 | Buy Now | 177.78% | Morgan Stanley | Erin Wright | — | Initiates | → Overweight | Get Alert |
| 10/28/2021 | Buy Now | 136.11% | Stifel | Jonathan Block | — | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for Elanco Animal Health (ELAN) stock?
The latest price target for Elanco Animal Health (NYSE:ELAN) was reported by Barclays on June 28, 2024. The analyst firm set a price target for $21.00 expecting ELAN to rise to within 12 months (a possible 45.83% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Elanco Animal Health (ELAN)?
The latest analyst rating for Elanco Animal Health (NYSE:ELAN) was provided by Barclays, and Elanco Animal Health maintained their overweight rating.
When was the last upgrade for Elanco Animal Health (ELAN)?
The last upgrade for Elanco Animal Health Inc happened on January 5, 2024 when Stifel raised their price target to $20. Stifel previously had a hold for Elanco Animal Health Inc.
When was the last downgrade for Elanco Animal Health (ELAN)?
The last downgrade for Elanco Animal Health Inc happened on August 18, 2022 when Morgan Stanley changed their price target from $37 to $22 for Elanco Animal Health Inc.
When is the next analyst rating going to be posted or updated for Elanco Animal Health (ELAN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Elanco Animal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Elanco Animal Health was filed on June 28, 2024 so you should expect the next rating to be made available sometime around June 28, 2025.
Is the Analyst Rating Elanco Animal Health (ELAN) correct?
While ratings are subjective and will change, the latest Elanco Animal Health (ELAN) rating was a maintained with a price target of $23.00 to $21.00. The current price Elanco Animal Health (ELAN) is trading at is $14.40, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.